These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24300522)

  • 41. Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data.
    Kombrink K; Munk A; Friede T
    Stat Med; 2013 Aug; 32(18):3055-66. PubMed ID: 23508697
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sample size estimation for non-inferiority trials of time-to-event data.
    Crisp A; Curtis P
    Pharm Stat; 2008; 7(4):236-44. PubMed ID: 17583558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Designing follow-up intervals.
    Raab GM; Davies JA; Salter AB
    Stat Med; 2004 Oct; 23(20):3125-37. PubMed ID: 15449335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Robust tests for treatment comparisons based on recurrent event responses.
    Cook RJ; Lawless JF; Nadeau C
    Biometrics; 1996 Jun; 52(2):557-71. PubMed ID: 8672703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Joint modeling of zero-inflated panel count and severity outcomes.
    Juarez-Colunga E; Silva GL; Dean CB
    Biometrics; 2017 Dec; 73(4):1413-1423. PubMed ID: 28314056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two-wave two-phase outcome-dependent sampling designs, with applications to longitudinal binary data.
    Tao R; Mercaldo ND; Haneuse S; Maronge JM; Rathouz PJ; Heagerty PJ; Schildcrout JS
    Stat Med; 2021 Apr; 40(8):1863-1876. PubMed ID: 33442883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Search for efficient complete and planned missing data designs for analysis of change.
    Wu W; Jia F; Rhemtulla M; Little TD
    Behav Res Methods; 2016 Sep; 48(3):1047-61. PubMed ID: 26170055
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design of clinical trials for recurrent events with periodic monitoring.
    Matsui S; Miyagishi H
    Stat Med; 1999 Nov; 18(22):3005-20. PubMed ID: 10544303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Applying planned missingness designs to longitudinal panel studies in developmental science: An overview.
    Wu W; Jia F
    New Dir Child Adolesc Dev; 2021 Jan; 2021(175):35-63. PubMed ID: 33470035
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Power considerations for clinical trials using multivariate time-to-event data.
    Hughes MD
    Stat Med; 1997 Apr; 16(8):865-82. PubMed ID: 9160485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statistical analysis of mixed recurrent event data with application to cancer survivor study.
    Zhu L; Tong X; Zhao H; Sun J; Srivastava DK; Leisenring W; Robison LL
    Stat Med; 2013 May; 32(11):1954-63. PubMed ID: 23139023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Efficiency of Split Panel Designs in an Analysis of Variance Model.
    Liu X; Wang WG; Liu HJ
    PLoS One; 2016; 11(5):e0154913. PubMed ID: 27163447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regression toward the mean in 2 x 2 crossover designs with baseline measurements.
    Grender JM; Johnson WD; Elston RC
    Stat Med; 1992 Apr; 11(6):727-41. PubMed ID: 1594812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Semiparametric Regression Analysis of Panel Count Data: A Practical Review.
    Chiou SH; Huang CY; Xu G; Yan J
    Int Stat Rev; 2019 Apr; 87(1):24-43. PubMed ID: 34366547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal time lags in panel studies.
    Dormann C; Griffin MA
    Psychol Methods; 2015 Dec; 20(4):489-505. PubMed ID: 26322999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alternative Design and Analytical Techniques for Longitudinal Rheumatology Studies: Improved Understanding of Outcomes.
    Lim LSH; Feldman BM; Lix LM
    Rheum Dis Clin North Am; 2018 May; 44(2):189-201. PubMed ID: 29622291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sample size requirements and length of study for testing interaction in a 2 x k factorial design when time-to-failure is the outcome [corrected].
    Peterson B; George SL
    Control Clin Trials; 1993 Dec; 14(6):511-22. PubMed ID: 8119066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review of environmental monitoring methods: survey designs.
    McDonald TL
    Environ Monit Assess; 2003 Jul; 85(3):277-92. PubMed ID: 12841690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent first hitting times in Wiener diffusion under several observation schemes.
    Whitmore GA; Ramsay T; Aaron SD
    Lifetime Data Anal; 2012 Apr; 18(2):157-76. PubMed ID: 22350567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.